May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
Johnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related claims against it have merit” getty Stock image of baby powder Johnson & Johnson has offered ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...
As of June 04, 2024, Johnson & Johnson had a $355.6 billion market capitalization, putting it in the 100th percentile of companies in the Pharmaceuticals industry. Currently, Johnson & Johnson’s price ...
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...
Johnson & Johnson’s MedTech division said Tuesday it plans to submit an application to the U.S. Food and Drug Administration next year to start clinical trials of its general surgery robot. Ottava, ...
Both these factors can be tied in part to J&J’s strong presence in the consumer sector – but behind household name products is a strong pharmaceutical backbone that has emerged over the ...
Samuel Johnson was born in Lichfield, Staffordshire, on 18 September 1709. His father was a bookseller. He was educated at Lichfield Grammar School and spent a brief period at Oxford University ...